Author:
Monga Neerav,Garside Jamie,Gurung Binu,Quigley Joan,O’Donovan Peter,Tapprich Christoph,Nastoupil Loretta,Thieblemont Catherine,Loefgren Christina
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference56 articles.
1. BMJ Best Practice. Non-Hodgkin’s Lymphoma: classification 2016. Available at: http://bestpractice.bmj.com/best-practice/monograph/312/basics/classification.html. Accessed 18 Oct 2016.
2. Chao MP. Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma—novel and emerging therapies. Cancer Manag Res. 2013;5:251–69. https://doi.org/10.2147/cmar.s34273.
3. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration.
4. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–84. https://doi.org/10.7326/m14-2385.
5. Centre for Reviews and Dissemination. Systematic Reviews: CRD’s guidance for undertaking reviews in healthcare. 2009. https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献